Document is current
Any future updates will be listed below
-
Authors
Ihara, Keiko
Ohtani, Seiya
Watanabe, Narumi
Takahashi, Nobuyuki
Miyazaki, Naoki
Ishizuchi, Kei
Hori, Satoko
Takemura, Ryo
Nakahara, Jin
Takizawa, Tsubasa
-
Funding
Funding for this research was provided by:
JSPS KAKENHI (22K15693 to TT)
Keio University Global Research Institute (Start-up grant)
- License Information
-
More Information
Article History
Received: 7 February 2023
Accepted: 24 February 2023
First Online: 9 March 2023
Declarations
:
: This study was approved by the Ethics Committee of the Keio University School of Medicine (approval number: 20211144). Patients were informed about this observational study via the institute’s website and could opt out of the study. The need for informed consent was waived by the Ethics Committee of the Keio University School of Medicine in accordance with national regulations (Ethical Guidelines for Medical and Biological Research Involving Human Subjects). This study was performed in accordance with relevant guidelines and regulations.
: Not applicable.
: TT serves as an adviser for Eli Lilly Japan, Otsuka, and Amgen. TT received speaker honoraria from Eli Lilly Japan, Daiichi Sankyo, Otsuka, Amgen, Kowa, Kyowa Kirin, Eisai, UCB Japan, Takeda, and Santen Pharmaceutical and research funding from Eli Lilly Japan and Tsumura outside the submitted work. JN received honoraria and research scholarships from Amgen and Daiichi Sankyo. The authors have no relevant financial or nonfinancial interests to disclose.
